Salt Lake City, UT, United States of America

Helena Safavi-Hemami

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: University of Utah Research Foundation, Walter and Eliza Hall Institute of Medical Research. Active years: 2022-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Helena Safavi-Hemami. Retrieved from https://idiyas.com/inventor/helena-safavi-hemami

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Helena Safavi-Hemami

Introduction

Helena Safavi-Hemami is a prominent inventor based in Salt Lake City, UT (US). She has made significant contributions to the field of biochemistry, particularly in the development of insulin analogs. With a total of two patents to her name, her work has the potential to impact therapeutic methods for diabetes management.

Latest Patents

Her latest patents focus on insulin analogs, specifically those with shortened B chains. These inventions also explore the crystal structure of insulin derived from the venom of cone snails. The methods outlined in her patents aim to utilize this structural information to design insulin analogs that can effectively interact with or modulate the insulin receptor. Additionally, her patents discuss therapeutic and prophylactic methods that utilize these innovative insulin analogs.

Career Highlights

Helena has worked with esteemed organizations such as the University of Utah Research Foundation and the Walter and Eliza Hall Institute of Medical Research. Her career reflects a commitment to advancing medical research and improving patient outcomes through innovative solutions.

Collaborations

Some of her notable coworkers include John Gerbrandt Tasman Menting and Brian John Smith. Their collaborative efforts have contributed to the success of her research and inventions.

Conclusion

Helena Safavi-Hemami's work in the field of insulin analogs showcases her dedication to innovation in medical research. Her patents hold promise for enhancing diabetes treatment and improving the quality of life for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…